• Home
  • About Us
  • Events
  • Submissions
  • Advertise
  • Contact Us
  • NewsVoir
  • Newswire
  • Nasheman Urdu ePaper

Nasheman

India's largest selling Urdu weekly, now also in English

  • News & Politics
    • India
    • Indian Muslims
    • Muslim World
  • Culture & Society
  • Opinion
  • In Focus
  • Human Rights
  • Photo Essays
  • Multimedia
    • Infographics
    • Podcasts
You are here: Home / News & Politics / World / AstraZeneca’s COVID-19 vaccine reaches phase 3 clinical trials in US, says Donald Trump

AstraZeneca’s COVID-19 vaccine reaches phase 3 clinical trials in US, says Donald Trump

September 1, 2020 by Nasheman

The UK-based global biopharmaceutical company AstraZeneca is leading the trial as regulatory sponsor.

US President Donald Trump speaks during a press briefing. (Photo | AP)

WASHINGTON: US President Donald Trump has announced that the vaccine for coronavirus being developed by AstraZeneca has reached phase three clinical trials in the country and is very close to being finalised for approval.

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.

“I am pleased to announce that AstraZeneca vaccine has reached phase three clinical trials,” Trump told reporters at the White House on Monday.

“That’s joining another group of vaccines that are very close to the end, and hopefully, approval,” he added.

AstraZeneca is one of the leaders in the race to develop COVID-19 vaccine.

Other companies that have COVID-19 vaccines in phase 3 trials include Moderna Inc and Pfizer Inc.

“In the United States, we’re doing things that nobody thought would have been even possible. This is a process that would have taken, in some cases, years, and we did it in a matter of months,” Trump said.

The National Institute of Health separately announced that Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222 will enroll approximately 30,000 adult volunteers at 80 sites in the US to evaluate if the candidate vaccine can prevent symptomatic COVID-19.

The UK-based global biopharmaceutical company AstraZeneca is leading the trial as regulatory sponsor.

“Safe and effective vaccines will be essential to meet the global need for widespread protection against COVID-19,” said National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S Fauci.

“Positive results from preclinical research led by NIH scientists supported the rapid development of this vaccine candidate, which has also showed promise in early-stage clinical trials,” he said.

Oxford University’s Jenner Institute and Oxford Vaccine Group have developed AZD1222.

The candidate vaccine was licensed to AstraZeneca for further development.

Trump told reporters that the US remains on track to deliver a vaccine very rapidly in record time.

“Over the last month, new cases in the United States have declined by 38 per cent. Last week, we announced a breakthrough in testing that will allow us to have over 150 million rapid, point-of-care tests.

“These tests return results in less than 15 minutes, and many will be deployed to nursing homes,” he said.

“We’re focusing very strongly on nursing homes, assisted living facilities and other locations that serve high-risk populations.

“So we’re going to have the 15-minute, and less, tests, and we will have 150 million rapid point-of-care tests,” Trump said.

The US has so far recorded 6,030,782 coronavirus cases and 183,596 fatalities — both the numbers highest in the world.

Share this:

  • Tweet
  • Print
  • WhatsApp

Related

Filed Under: World

About Nasheman

Follow Us

  • Facebook
  • Twitter
  • YouTube

KNOW US

  • About Us
  • Corporate News
  • FAQs
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh

GET INVOLVED

  • Corporate News
  • Letters to Editor
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh
  • Submissions

PROMOTE

  • Advertise
  • Corporate News
  • Events
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh

Archives

  • May 2025 (9)
  • April 2025 (50)
  • March 2025 (35)
  • February 2025 (34)
  • January 2025 (43)
  • December 2024 (83)
  • November 2024 (82)
  • October 2024 (156)
  • September 2024 (202)
  • August 2024 (165)
  • July 2024 (169)
  • June 2024 (161)
  • May 2024 (107)
  • April 2024 (104)
  • March 2024 (222)
  • February 2024 (229)
  • January 2024 (102)
  • December 2023 (142)
  • November 2023 (69)
  • October 2023 (74)
  • September 2023 (93)
  • August 2023 (118)
  • July 2023 (139)
  • June 2023 (52)
  • May 2023 (38)
  • April 2023 (48)
  • March 2023 (166)
  • February 2023 (207)
  • January 2023 (183)
  • December 2022 (165)
  • November 2022 (229)
  • October 2022 (224)
  • September 2022 (177)
  • August 2022 (155)
  • July 2022 (123)
  • June 2022 (190)
  • May 2022 (204)
  • April 2022 (310)
  • March 2022 (273)
  • February 2022 (311)
  • January 2022 (329)
  • December 2021 (296)
  • November 2021 (277)
  • October 2021 (237)
  • September 2021 (234)
  • August 2021 (221)
  • July 2021 (237)
  • June 2021 (364)
  • May 2021 (282)
  • April 2021 (278)
  • March 2021 (293)
  • February 2021 (192)
  • January 2021 (222)
  • December 2020 (170)
  • November 2020 (172)
  • October 2020 (187)
  • September 2020 (194)
  • August 2020 (61)
  • July 2020 (58)
  • June 2020 (56)
  • May 2020 (36)
  • March 2020 (48)
  • February 2020 (109)
  • January 2020 (162)
  • December 2019 (174)
  • November 2019 (120)
  • October 2019 (104)
  • September 2019 (88)
  • August 2019 (159)
  • July 2019 (122)
  • June 2019 (66)
  • May 2019 (276)
  • April 2019 (393)
  • March 2019 (477)
  • February 2019 (448)
  • January 2019 (693)
  • December 2018 (736)
  • November 2018 (572)
  • October 2018 (611)
  • September 2018 (692)
  • August 2018 (667)
  • July 2018 (469)
  • June 2018 (440)
  • May 2018 (616)
  • April 2018 (774)
  • March 2018 (338)
  • February 2018 (159)
  • January 2018 (189)
  • December 2017 (142)
  • November 2017 (122)
  • October 2017 (146)
  • September 2017 (178)
  • August 2017 (201)
  • July 2017 (222)
  • June 2017 (155)
  • May 2017 (205)
  • April 2017 (156)
  • March 2017 (178)
  • February 2017 (195)
  • January 2017 (149)
  • December 2016 (143)
  • November 2016 (169)
  • October 2016 (167)
  • September 2016 (137)
  • August 2016 (115)
  • July 2016 (117)
  • June 2016 (125)
  • May 2016 (171)
  • April 2016 (152)
  • March 2016 (201)
  • February 2016 (202)
  • January 2016 (217)
  • December 2015 (210)
  • November 2015 (177)
  • October 2015 (284)
  • September 2015 (243)
  • August 2015 (250)
  • July 2015 (188)
  • June 2015 (216)
  • May 2015 (281)
  • April 2015 (306)
  • March 2015 (297)
  • February 2015 (280)
  • January 2015 (245)
  • December 2014 (287)
  • November 2014 (254)
  • October 2014 (185)
  • September 2014 (98)
  • August 2014 (8)

Copyright © 2025 · News Pro Theme on Genesis Framework · WordPress · Log in